CI&T Inc. (NYSE:CINT – Get Free Report) Director Fernando Matt Borges Martins acquired 6,629 shares of the company’s stock in a transaction that occurred on Tuesday, October 6th. The stock was purchased at an average cost of $3.15 per share, with a total value of $20,881.35. Following the acquisition, the director directly owned 10,752 shares of the company’s stock, valued at $33,868.80. This trade represents a 160.78% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Fernando Matt Borges Martins also recently made the following trade(s):
- On Wednesday, October 7th, Fernando Matt Borges Martins acquired 9,116 shares of CI&T stock. The shares were purchased at an average price of $3.12 per share, with a total value of $28,441.92.
- On Thursday, October 1st, Fernando Matt Borges Martins bought 4,123 shares of CI&T stock. The shares were purchased at an average cost of $3.18 per share, for a total transaction of $13,111.14.
CI&T Stock Performance
NYSE:CINT opened at $3.10 on Friday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.31 and a quick ratio of 1.31. The firm has a market capitalization of $416.53 million, a price-to-earnings ratio of 10.67 and a beta of 0.83. The company’s 50-day moving average is $3.34 and its two-hundred day moving average is $3.72. CI&T Inc. has a 1-year low of $2.80 and a 1-year high of $5.80.
Analyst Ratings Changes
Several equities research analysts have issued reports on CINT shares. TD Cowen cut their target price on CI&T from $6.00 to $5.00 and set a “buy” rating for the company in a research note on Wednesday, August 12th. JPMorgan Chase & Co. decreased their target price on CI&T from $6.00 to $5.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 12th. Wedbush lowered shares of CI&T from an “outperform” rating to a “neutral” rating and cut their price target for the stock from $7.00 to $4.00 in a research note on Tuesday, July 21st. UBS Group reduced their price target on shares of CI&T from $7.20 to $6.20 and set a “buy” rating on the stock in a research report on Wednesday, August 12th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of CI&T in a research note on Friday, September 25th. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, CI&T presently has an average rating of “Moderate Buy” and a consensus target price of $6.08.
Read Our Latest Stock Analysis on CINT
Institutional Trading of CI&T
Several hedge funds have recently modified their holdings of CINT. GMT Capital Corp purchased a new position in CI&T in the fourth quarter valued at $1,786,000. Beacon Hill Wealth Management LTD. purchased a new stake in CI&T during the 2nd quarter worth about $617,000. Lazard Asset Management LLC increased its holdings in CI&T by 6.4% during the 1st quarter. Lazard Asset Management LLC now owns 102,742 shares of the company’s stock worth $521,000 after purchasing an additional 6,171 shares during the period. NewEdge Advisors LLC acquired a new stake in CI&T in the 1st quarter valued at about $181,000. Finally, R Squared Ltd raised its position in CI&T by 24.1% in the 1st quarter. R Squared Ltd now owns 34,521 shares of the company’s stock valued at $175,000 after purchasing an additional 6,707 shares in the last quarter. 92.45% of the stock is currently owned by institutional investors and hedge funds.
CI&T Company Profile
CI&T (NYSE:CINT) is a global technology and digital transformation services company that helps organizations modernize their operations, customer experiences and technology platforms. Its offerings include business and technology strategy, product design, software engineering, cloud modernization, data and artificial intelligence, cybersecurity, and managed technology services.
Founded in 1995 and headquartered in Campinas, Brazil, CI&T works with clients across industries such as consumer products, financial services, healthcare, manufacturing and retail.
See Also
- Five stocks we like better than CI&T
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for CI&T Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI&T and related companies with MarketBeat.com's FREE daily email newsletter.
